Kay, Emily J. http://orcid.org/0000-0002-3398-0960
Paterson, Karla
Riera-Domingo, Carla http://orcid.org/0000-0001-7277-234X
Sumpton, David http://orcid.org/0000-0002-9004-4079
Däbritz, J. Henry M.
Tardito, Saverio http://orcid.org/0000-0002-5294-8683
Boldrini, Claudia
Hernandez-Fernaud, Juan R. http://orcid.org/0000-0003-2807-0601
Athineos, Dimitris http://orcid.org/0000-0001-5298-7941
Dhayade, Sandeep
Stepanova, Ekaterina
Gjerga, Enio
Neilson, Lisa J.
Lilla, Sergio http://orcid.org/0000-0003-3142-7640
Hedley, Ann
Koulouras, Grigorios http://orcid.org/0000-0002-1180-1730
McGregor, Grace
Jamieson, Craig
Johnson, Radia Marie
Park, Morag http://orcid.org/0000-0001-5400-606X
Kirschner, Kristina
Miller, Crispin
Kamphorst, Jurre J.
Loayza-Puch, Fabricio http://orcid.org/0000-0002-2999-8594
Saez-Rodriguez, Julio
Mazzone, Massimiliano
Blyth, Karen
Zagnoni, Michele http://orcid.org/0000-0003-3198-9491
Zanivan, Sara http://orcid.org/0000-0002-9880-9099
Article History
Received: 23 September 2021
Accepted: 10 May 2022
First Online: 27 June 2022
Change Date: 4 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42255-022-00632-7
Competing interests
: S.Z. reports that part of this research was conducted in a collaboration with Cancer Research Horizon – LifeArc – Ono Pharmaceutical Co., Ltd. Alliance. J.S.-R. reports funding from GSK and Sanofi and fees from Travere Therapeutics and Astex Therapeutics. All other authors have no competing interests.